Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2018

Nov 30, 2018

29875_dirs_2018-11-30_58583249-945b-468f-9921-1121f34c6e05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-11-28

Reporting Person: Bertolini Mark T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-28 Common Stock A 1308 $80.27 Acquired 1308 Direct
2018-11-28 Common Stock A 141677 Acquired 142985 Direct
2018-11-28 Common Stock A 100072 Acquired 100072 Indirect
2018-11-28 Common Stock A 89726 Acquired 89726 Indirect
2018-11-28 Common Stock A 90127 Acquired 90127 Indirect
2018-11-28 Common Stock A 217802 Acquired 217802 Indirect
2018-11-28 Common Stock A 12534 Acquired 12534 Indirect
2018-11-28 Common Stock A 112808 Acquired 112808 Indirect

Footnotes

F1: Consists of common stock issued as a pro rata portion of the retainer payable for the reporting person's 2018-2019 Board service, pursuant to the Registrant's 2017 Incentive Compensation Plan.

F2: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share.

F3: Represents shares held in Charitable Lead Annuity Trust for which the reporting person is the investment advisor.

F4: Represents shares held by 2017 Grantor Retained Annuity Trust ("GRAT") for which the reporting person is the sole trustee.

F5: Represents shares held by 2017 GRAT II for which the reporting person is the sole trustee.

F6: Represents shares held by 2018 GRAT for which the reporting person is the sole trustee.

F7: Represents shares held by a 2018 Trust for which the reporting person is the investment advisor.

F8: Represents shares held by a 2016 Trust for which the reporting person is the investment advisor.